BlackRock’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $684M | Sell |
|
|||||
|
2021
Q2 | $553M | Sell |
|
|||||
|
2021
Q1 | $628M | Buy |
|
|||||
|
2020
Q4 | $590M | Sell |
|
|||||
|
2020
Q3 | $522M | Buy |
|
|||||
|
2020
Q2 | $423M | Sell |
|
|||||
|
2020
Q1 | $460M | Buy |
|
|||||
|
2019
Q4 | $259M | Sell |
|
|||||
|
2019
Q3 | $204M | Buy |
|
|||||
|
2019
Q2 | $202M | Buy |
|
|||||
|
2019
Q1 | $223M | Buy |
|
|||||
|
2018
Q4 | $193M | Buy |
|
|||||
|
2018
Q3 | $249M | Buy |
|
|||||
|
2018
Q2 | $204M | Buy |
|
|||||
|
2018
Q1 | $158M | Sell |
|
|||||
|
2017
Q4 | $201M | Buy |
|
|||||
|
2017
Q3 | $160M | Buy |
|
|||||
|
2017
Q2 | $122M | Buy |
|
|||||
|
2017
Q1 | $97.3M | Buy |
|
|||||
|
2016
Q4 | $2.01M | Buy |
|
|||||
|
2016
Q3 | $1.27M | Sell |
|
|||||
|
2016
Q2 | $1.21M | Buy |
|
|||||
|
2016
Q1 | $889K | Buy |
|
|||||
|
2015
Q4 | $1.4M | Sell |
|
|||||
|
2015
Q3 | $834K | Buy |
|
|||||
|
2015
Q2 | $1.05M | Sell |
|
|||||
|
2015
Q1 | $1.29M | Buy |
|
|||||
|
2014
Q4 | $1.26M | Buy |
|
|||||
|
2014
Q3 | $12K | Hold |
|
|||||
|
2014
Q2 | $13K | Buy |
|
|||||
|
2014
Q1 | $7K | Buy |
|